{
    "ticker": "STXD",
    "name": "Simulations Plus, Inc.",
    "description": "Simulations Plus, Inc. is a leading provider of software for pharmaceutical research and development, specializing in simulation and modeling solutions that accelerate drug discovery and development processes. Founded in 1996, the company has established itself as a crucial partner for pharmaceutical and biotechnology companies, offering advanced software tools that enhance the efficiency of drug formulation and dosage regimen designs. Their flagship products, including GastroPlus, ADMET Predictor, and DDDPlus, empower scientists to predict the absorption, distribution, metabolism, excretion, and toxicity (ADMET) of drug candidates, thereby reducing the need for costly and time-consuming laboratory experiments. Simulations Plus is committed to continuous innovation, utilizing cutting-edge technologies such as artificial intelligence and machine learning to improve the predictive capabilities of their software. The company places a strong emphasis on customer collaboration and training, ensuring that users can maximize the value of their tools in real-world applications. With a mission to support the pharmaceutical industry in bringing safe and effective drugs to market faster and more cost-effectively, Simulations Plus is at the forefront of transforming drug development processes.",
    "industry": [
        "Pharmaceuticals",
        "Software"
    ],
    "headquarters": "Lancaster, California, USA",
    "founded": "1996",
    "website": "https://www.simulations-plus.com",
    "ceo": "Walt Woltosz",
    "social_media": {
        "twitter": "https://twitter.com/simulationsplus",
        "linkedin": "https://www.linkedin.com/company/simulations-plus/"
    },
    "investor_relations": "https://www.simulations-plus.com/investor-relations/",
    "key_executives": [
        {
            "name": "Walt Woltosz",
            "position": "CEO"
        },
        {
            "name": "John DiBella",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceutical Simulation Software",
            "products": [
                "GastroPlus",
                "ADMET Predictor",
                "DDDPlus"
            ]
        },
        {
            "category": "Consulting Services",
            "products": [
                "Custom Software Development",
                "Training Services"
            ]
        }
    ],
    "seo": {
        "meta_title": "Simulations Plus, Inc. | Pharmaceutical Software Solutions",
        "meta_description": "Explore Simulations Plus, Inc., a leader in software for pharmaceutical research. Discover innovative simulation tools that streamline drug development.",
        "keywords": [
            "Simulations Plus",
            "Pharmaceutical Software",
            "Drug Development",
            "GastroPlus",
            "ADMET Predictor"
        ]
    },
    "faq": [
        {
            "question": "What does Simulations Plus specialize in?",
            "answer": "Simulations Plus specializes in software solutions for pharmaceutical research and development."
        },
        {
            "question": "Who is the CEO of Simulations Plus?",
            "answer": "Walt Woltosz is the CEO of Simulations Plus, Inc."
        },
        {
            "question": "Where is Simulations Plus headquartered?",
            "answer": "Simulations Plus is headquartered in Lancaster, California, USA."
        },
        {
            "question": "What are the main products offered by Simulations Plus?",
            "answer": "The main products include GastroPlus, ADMET Predictor, and DDDPlus."
        },
        {
            "question": "When was Simulations Plus founded?",
            "answer": "Simulations Plus was founded in 1996."
        }
    ],
    "competitors": [
        "MRVL",
        "BMRN",
        "CGEN"
    ],
    "related_stocks": [
        "VRTX",
        "AMGN",
        "REGN",
        "GILD"
    ]
}